You are here:

Novo Nordisk Ltd

Name SMC ID No Status Sub. Type
 
Biphasic insulin aspart 30 (Novomix 30®) 06/02 Not Recommended Full submission
Biphasic insulin aspart 30 (NovoMix 30®) 06/02 Accepted Resubmission
insulin aspart (Fiasp) 1227/17 Accepted Abbreviated Submission
insulin degludec (Tresiba) 856/13 Not Recommended Full submission
insulin degludec (Tresiba) 856/13 Accepted Resubmission
insulin degludec (Tresiba) 856/13 Not Recommended Resubmission
insulin degludec (Tresiba) 1060/15 Not Recommended Non submission
insulin degludec/liraglutide (Xultophy) 1088/15 Restricted Full submission
insulin detemir (Levemir) 780/12 Restricted Abbreviated Submission
insulin detemir (Levemir) 1126/16 Restricted Abbreviated Submission
Insulin detemir (Levemir®) 110/04 Restricted Full submission
Insulin detemir (Levemir®) 138/04 Restricted Abbreviated Submission
insulin detemir, 100 U/ml solution for injection via InnoLet device (Levemir in InnoLet) 393/07 Restricted Abbreviated Submission
liraglutide (Saxenda) 1247/17 Not Recommended Non submission
liraglutide (Victoza) 1044/15 Accepted Full submission
liraglutide (Victoza) 585/09 Restricted Full submission
liraglutide (Victoza) 1192/16 Not Recommended Non submission
Somatropin (Norditropin SimpleXx) 260/06 Restricted Abbreviated Submission

Back